Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study

Figure 2

Reported incidences of local and systemic reactions after first and second dose of immunization. White bar indicates mild to moderate reaction while gray bar indicates severe reaction. A, B and C indicate the incidence of reaction among participants without priming, participant primed with A/Indonesia/05/2005 and participants primed with both A/Vietnam/1194/2004 and A/Indonesia/05/2005, respectively.

Back to article page